01661nas a2200673   4500000000100000000000100001000000100002008004100003653001100044653001100055653001400066653001500080653001600095653001000111653001600121653002100137653003100158653003100189653002100220653002500241653001700266653002200283653001500305100001900320700001100339700001800350700001400368700001600382700001300398700002300411700001600434700001200450700001800462700001300480700002100493700001100514700001200525700001500537700001300552700001800565700001200583700001500595700001500610700001200625700001600637700001300653700001300666700001200679700001400691700002000705700001200725700002100737700002300758245015800781250001500939300001200954490000700966020001400973       2023                            d10aHumans10aFemale10aPregnancy10aAdolescent10aYoung Adult10aAdult10aMiddle Aged10a*Risk Assessment10aPregnancy Trimester, First10aSurveys and Questionnaires10aNorthern Ireland10aCase-Control Studies10aepidemiology10amaternal medicine10aObstetrics1 aA. Subramanian1 aS. Lee1 aS. Sudasinghe1 aS. Wambua1 aK. Phillips1 aM. Singh1 aA. Azcoaga-Lorenzo1 aN. Cockburn1 aJ. Wang1 aA. Fagbamigbe1 aM. Usman1 aC. Damase-Michel1 aC. Yau1 aL. Kent1 aC. McCowan1 aReilly D1 aG. Santorelli1 aH. Hope1 aJ. Kennedy1 aM. Mhereeg1 aK. Abel1 aK. Eastwood1 aM. Black1 aM. Loane1 aN. Moss1 aS. Brophy1 aP. Brocklehurst1 aH. Dolk1 aC. Nelson-Piercy1 aK. Nirantharakumar00aDetection and evaluation of signals associated with exposure to individual and combination of medications in pregnancy: a signal detection study protocol  a2023/10/12  ae0731620 v13  a2044-6055